![Documents Document Submission](/images/default-source/default-album/document-review/documents.jpg?sfvrsn=d9b80dc1_1)
Rate This Document
Development and Commercialization of Combination Products A Drug-Eluting Stent Case Study TAXUS Express2 - From Development to Approval
- Description: October 2004, by Kathleen M. Miller, Program Manager Drug Delivery, Boston Scientific (4.15 MB)
- Published on: Nov 15, 2023
- Rating Period:
Your rating for this document has already been submitted